Droxidopa Impurity 5 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Erythro-β,3-dihydroxy-DL-tyrosine is norepinephrine precursor with therapeutic effect to treat postprandial hypotension in patients with autonomic failure.

Droxidopa Impurity 5 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Droxidopa Impurity 5 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Standardpharm Co. Ltd.	86-714-3992388	overseasales1@yongstandards.com	United States	14332	58
China National Standard Pharmaceutical Corporation Limited	+8615391658522	overseasales@yongstandards.com	China	11922	58
Shanghai Kewel Chemical Co., Ltd.	021-64609169 18901607656	greensnown@163.com	China	9906	50
Guangzhou Dreampharm Biotechnology Co., Ltd.	020-36607679 17825480238	3008233746@qq.com	China	9919	12
Jinan blalong chemical co. LTD	2710913286@.com	1513643261@qq.com	China	14246	58
Shenzhen ruikai de biotechnology co., ltd.	0755-61348847 17820674378	2682116078@qq.com	China	7843	58
Shenzhen Jianyi Biotechnology Co., Ltd	0755-84826604	3001783715@qq.com	CHINA	2896	58
Guangzhou Juntang Technology Co., Ltd	020-36607679 13502246435	sales@dmstandards.com	China	10945	58
QUALITY CONTROL SOLUTIONS LTD.	0755-66853366; 13670046396	ORDERS@QCSRM.COM	China	24342	58
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd	18162595016; 18162595016	3287908757@qq.com	China	9122	58

---

• Droxidopa Impurity 5
• Droxidopa Impurity 11 (DL-erythro-Droxidopa)
• Droxidopa Impurity 11
• D-Tyrosine, β,3-dihydroxy-, (βR)-rel-
• Erythro-β,3-dihydroxy-DL-tyrosine
• (2R,3S)-2-Amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acid compound with (2S,3R)-2-amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic Acid (1:1)
• 16322-99-9